A new survey has found that a majority of people aged 50 or over in the UK who have long-term health conditions would have no problem with being automatically enrolled int
Industry stakeholders have moved beyond considering patients as clinical trial “subjects”, and instead recognise the tremendous value of viewing those most impacted by a disease as partners
OneOncology has joined forces with Verily to speed up and improve the efficiency of clinical trials run through its network of independent cancer treatment centres in the
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
